Nurami Medical finishes recruitment for tissue damage clinical trialNurami Medical's new product – ArtiFascia – is a synthetic implant for restoring and repairing membranes after surgical procedures. From left: Nurami co-founder Nora Nseir Manassa, PlasFree Operations Manager Samah Waked and PlasFree R&D manager Dr. Nuha Higazi(photo credit: Courtesy)
